Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Nov 2022 for LogicBio Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Daniel Gruskin: trading record in brief
Daniel Gruskin is a declared insider of LogicBio Therapeutics, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 6 August 2021 and 16 November 2022, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 17 November 2022, the filings show a transaction in LogicBio Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Daniel Gruskin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
3,331 sharesCommon StockSEC:0000899243-22-036290:0
4,798 sharesCommon StockSEC:0001209191-21-050681:0
2 of 2 declarations
